Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SHBG | P04278 | 7/20 | 0.74 |
| ▸ | NR3C1 | P04150 | 4/20 | 0.74 |
| ▸ | PGR | P06401 | 3/20 | 0.74 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.74 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.74 |
| ▸ | HTR2B | P41595 | 1/20 | 0.74 |
| ▸ | LMNA | P02545 | 7/20 | 0.70 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.70 |
| ▸ | TSHR | P16473 | 4/20 | 0.70 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.70 |
| ▸ | AR | P10275 | 3/20 | 0.70 |
| ▸ | MEN1 | O00255 | 2/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.70 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.70 |
| ▸ | THRB | P10828 | 1/20 | 0.70 |
| ▸ | ESR1 | P03372 | 1/20 | 0.70 |
| ▸ | SERPINA6 | P08185 | 6/20 | 0.68 |
| ▸ | BLM | P54132 | 4/20 | 0.68 |
| ▸ | MAPT | P10636 | 2/20 | 0.68 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL571189 | 1.00 | SHBG (0.74) | SHBGNR3C1PGRALDH1A1ADRA1A | |
| SCHEMBL3946610 | 1.00 | SHBG (0.74) | SHBGNR3C1PGRALDH1A1ADRA1A | |
| Topterone SCHEMBL140769 | 0.91 | SHBG (0.71) | SHBGNR3C1PGRALDH1A1ADRA1A | |
| Topterone SCHEMBL11730925 | 0.91 | SHBG (0.71) | SHBGNR3C1PGRALDH1A1ADRA1A | |
| Topterone SCHEMBL8846971 | 0.91 | SHBG (0.71) | SHBGNR3C1PGRALDH1A1ADRA1A | |
| Topterone SCHEMBL3844149 | 0.91 | SHBG (0.71) | SHBGNR3C1PGRALDH1A1ADRA1A | |
| SCHEMBL11728942 | 0.89 | SHBG (0.68) | SHBGNR3C1PGRALDH1A1ADRA1A | |
| SCHEMBL10393805 | 0.89 | SHBG (0.68) | SHBGNR3C1PGRALDH1A1ADRA1A | |
| SCHEMBL8236612 | 0.89 | SHBG (0.68) | SHBGNR3C1PGRALDH1A1ADRA1A | |
| SCHEMBL29437217 | 0.88 | SHBG (0.71) | SHBGNR3C1PGRALDH1A1ADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 380 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104825397-A | Controlled release delivery device containing organosol coating | ISA ODIDI | 2015-08-12 | — | — | CN | claimed |
| US-20090263476-A1 | Composition of Rapid Disintegrating Direct Compression Buccal Tablet | PROVIDENT BANK | 2009-10-22 | — | — | US | claimed |
| CN-101453993-A | Controlled release delivery device containing organosol coating | ISA ODIDI (CA) | 2009-06-10 | — | — | CN | claimed |
| EP-2007360-A1 | CONTROLLED RELEASE DELIVERY DEVICE COMPRISING AN ORGANOSOL COAT | Odidi, Isa (CA) | 2008-12-31 | — | — | EP | claimed |
| WO-2007112581-A1 | CONTROLLED RELEASE DELIVERY DEVICE COMPRISING AN ORGANOSOL COAT | ODIDI ISA (CA) | 2007-10-11 | — | — | WO | claimed |
| EP-1560502-A1 | ORAL VETERINARY DRUG DELIVERY SYSTEM AND/OR FEED ADDITIVE DELIVERY SYSTEM, PROCESS FOR THE PREPARATION AND USE THEREOF | Szoke, Annamaria (HU) | 2005-08-10 | — | — | EP | claimed |
| WO-2004039172-A1 | ORAL VETERINARY DRUG DELIVERY SYSTEM AND/OR FEED ADDITIVE DELIVERY SYSTEM, PROCESS FOR THE PREPARATION AND USE THEREOF | SZOKE ANNAMARIA (HU) | 2004-05-13 | — | — | WO | claimed |
| US-6004751-A | IDENTIFICATION OF A CANDIDATE INHIBITOR SUBSTANCE THAT IS AN ANTAGONIST OF SEBUM FORMATION | ARCH DEVELOPMENT CORPORATION (US) | 1999-12-21 | — | — | US | claimed |
| WO-1998008089-A9 | IDENTIFICATION OF ACTIVATORS AND INHIBITORS OF SEBUM FORMATION | — | 1998-05-07 | — | — | WO | claimed |
| WO-1998008089-A1 | IDENTIFICATION OF ACTIVATORS AND INHIBITORS OF SEBUM FORMATION | ARCH DEVELOPMENT CORPORATION (US) | 1998-02-26 | — | — | WO | claimed |
| US-4542128-A | 17α-Pregn-4-ene-3-oxo-21-carboxylic acid esters, process for the preparation thereof, and use thereof as medicinal agents | SCHERING AKTIENGESELLSCHAFT (DE) | 1985-09-17 | — | — | US | claimed |
| EP-4714407-A2 | DEVICES TO PROVIDE HANDS FREE SCLERAL DEPRESSION DURING OPHTHALMIC PROCEDURES | Alcon Inc. (CH) | 2026-03-25 | — | — | EP | disclosed |
| EP-3157408-B1 | DEVICES TO PROVIDE HANDS FREE SCLERAL DEPRESSION DURING OPHTHALMIC PROCEDURES | ALCON INC (CH) | 2026-03-25 | — | — | EP | disclosed |
| EP-3432940-B1 | COMPLEX BRAIDED SCAFFOLDS FOR IMPROVED TISSUE REGENERATION | BIOREZ INC (US) | 2025-11-05 | — | — | EP | disclosed |
| US-20250281509-A1 | SEQUENTIAL HORMONE THERAPY TO IMPROVE SURVIVAL AND ENHANCE RESPONSE TO IMMUNE THERAPY IN MEN WITH PROSTATE CANCER | THE JOHNS HOPKINS UNIVERSTY | 2025-09-11 | — | — | US | disclosed |
| US-4170518-A | Microbiological conversion of sterol derivatives to 5-androsten-17-one derivatives and their use | SCHERING AKTIENGESELLSCHAFT (DE) | 1979-10-09 | — | — | US | disclosed |
| US-4160027-A | OXYTOCICS, 4A,5A-EPOXY-2A-CYANO-3-OXOSTEROIDES, STEROIDO(2,3-O)ISOOXAZOLES | STERLING DRUG INC. (US) | 1979-07-03 | — | — | US | disclosed |
| US-4039669-A | DERMATOLOGICAL CONDITIONS, ACNE, STEROIDS | STERLING DRUG INC. (US) | 1977-08-02 | — | — | US | disclosed |
| US-3956316-A | PROGESTATIONAL AND SALT-RETAINING AGENTS | HOFFMANN-LA ROCHE INC. (US) | 1976-05-11 | — | — | US | disclosed |
| US-3944064-A | Self-monitored device for releasing agent at functional rate | ALZA CORPORATION (US) | 1976-03-16 | — | — | US | disclosed |